China Universal Asset Management Company’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $145K | Buy |
14,278
+31
| +0.2% | +$315 | 0.01% | 337 |
|
2025
Q1 | $79.5K | Sell |
14,247
-716
| -5% | -$4K | 0.01% | 376 |
|
2024
Q4 | $121K | Buy |
14,963
+1,395
| +10% | +$11.3K | 0.01% | 374 |
|
2024
Q3 | $139K | Buy |
13,568
+5,646
| +71% | +$57.9K | 0.02% | 328 |
|
2024
Q2 | $56K | Sell |
7,922
-5,000
| -39% | -$35.4K | 0.01% | 348 |
|
2024
Q1 | $178K | Buy |
12,922
+6,617
| +105% | +$91K | 0.02% | 305 |
|
2023
Q4 | $58K | Buy |
+6,305
| New | +$58K | 0.01% | 354 |
|
2022
Q4 | – | Sell |
-370
| Closed | -$1K | – | 438 |
|
2022
Q3 | $1K | Buy |
+370
| New | +$1K | ﹤0.01% | 405 |
|